Published in Acta Ophthalmol Scand on October 19, 2006
An analysis of normal variations in retinal nerve fiber layer thickness profiles measured with optical coherence tomography. J Glaucoma (2008) 1.54
Spectral domain optical coherence tomography in glaucoma: qualitative and quantitative analysis of the optic nerve head and retinal nerve fiber layer (an AOS thesis). Trans Am Ophthalmol Soc (2009) 1.26
The location of the inferior and superior temporal blood vessels and interindividual variability of the retinal nerve fiber layer thickness. J Glaucoma (2010) 1.16
Diagnostic capability of spectral-domain optical coherence tomography for glaucoma. Am J Ophthalmol (2012) 1.02
A comparative study of two methods of optic disc evaluation in patients of glaucoma. Oman J Ophthalmol (2013) 0.85
Reproducibility of measurements and variability of the classification algorithm of Stratus OCT in normal, hypertensive, and glaucomatous patients. Clin Ophthalmol (2009) 0.81
Interocular retinal nerve fiber layer thickness difference in normal adults. PLoS One (2015) 0.76
Adaptive optics optical coherence tomography in glaucoma. Prog Retin Eye Res (2016) 0.75
Clinical Utility of Optical Coherence Tomography in Glaucoma. Invest Ophthalmol Vis Sci (2016) 0.75
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol (2002) 14.17
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (2003) 8.76
Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology (2007) 4.79
A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol (2008) 3.46
Natural history of open-angle glaucoma. Ophthalmology (2009) 2.99
Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology (2006) 2.66
Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand (2003) 1.96
Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol (2005) 1.80
Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol (2004) 1.52
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma (2005) 1.25
Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol (2009) 1.25
Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology (2005) 1.21
Modelling the normal retinal nerve fibre layer thickness as measured by Stratus optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2006) 1.19
Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol (2012) 1.17
Glaucoma detection by Stratus OCT. J Glaucoma (2007) 1.13
The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res (2003) 1.13
TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. J Diabetes Complications (2008) 1.12
Trained artificial neural network for glaucoma diagnosis using visual field data: a comparison with conventional algorithms. J Glaucoma (2007) 1.10
Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study. Acta Ophthalmol Scand (2002) 1.10
Disc hemorrhages and treatment in the early manifest glaucoma trial. Ophthalmology (2008) 1.09
A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthalmol Scand (2002) 1.08
Glaucoma management in Sweden -- results from a nationwide survey. Acta Ophthalmol (2011) 1.07
Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol (2013) 1.03
A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology (2008) 1.02
Machine learning classifiers for glaucoma diagnosis based on classification of retinal nerve fibre layer thickness parameters measured by Stratus OCT. Acta Ophthalmol (2010) 0.97
Preservative-free treatment in glaucoma: who, when, and why. Eur J Ophthalmol (2013) 0.97
Glaucoma and mortality. Graefes Arch Clin Exp Ophthalmol (2004) 0.97
Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology (2005) 0.94
Performance of time-domain and spectral-domain Optical Coherence Tomography for glaucoma screening. Acta Ophthalmol (2010) 0.93
Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs. Ophthalmology (2006) 0.92
Factors associated with lifetime risk of open-angle glaucoma blindness. Acta Ophthalmol (2013) 0.92
Prevalence and severity of undetected manifest glaucoma: results from the early manifest glaucoma trial screening. Ophthalmology (2013) 0.90
Integration and fusion of standard automated perimetry and optical coherence tomography data for improved automated glaucoma diagnostics. BMC Ophthalmol (2011) 0.90
Stable refraction and visual acuity in diabetic patients with variable glucose levels under routine care. Acta Ophthalmol (2011) 0.88
Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial. Acta Ophthalmol (2010) 0.87
Normal intersubject threshold variability and normal limits of the SITA SWAP and full threshold SWAP perimetric programs. Invest Ophthalmol Vis Sci (2003) 0.86
Effects of input data on the performance of a neural network in distinguishing normal and glaucomatous visual fields. Invest Ophthalmol Vis Sci (2005) 0.86
Nordic research in ophthalmology. Acta Ophthalmol Scand (2003) 0.84
Appearance of the pattern deviation map as a function of change in area of localized field loss. Invest Ophthalmol Vis Sci (2004) 0.83
Optic disc hemorrhages and generalized vascular disease. J Glaucoma (2002) 0.82
Natural history of intraocular pressure in the early manifest glaucoma trial: A 6-year follow-up. Arch Ophthalmol (2010) 0.82
The nerve fibre layer symmetry test: computerized evaluation of human retinal nerve fibre layer thickness as measured by optical coherence tomography. Acta Ophthalmol Scand (2004) 0.80
Glaucomatous retinal nerve fibre layer defects may be identified in Stratus OCT images classified as normal. Acta Ophthalmol (2008) 0.80
Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial. Am J Ophthalmol (2011) 0.79
The effect of different criteria on the number of patients blind from open-angle glaucoma. BMC Ophthalmol (2011) 0.78
Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene. Ophthalmic Genet (2003) 0.78
Cataract epidemiology. Ophthalmology (2007) 0.76
Functional and structural change in diabetic eyes. Interim results from an ongoing longitudinal prospective study. Acta Ophthalmol (2012) 0.75
The effect of education on the assessment of optic nerve head photographs for the glaucoma diagnosis. BMC Ophthalmol (2011) 0.75
A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans. Br J Clin Pharmacol (2006) 0.75
On a mission from God: fighting publication bias. Acta Ophthalmol Scand (2002) 0.75
An evidence-based glaucoma guideline. Acta Ophthalmol Scand (2003) 0.75
[Open-angle glaucoma: diagnosis, follow up and treatment. A systematic literature review from SBU]. Lakartidningen (2010) 0.75
Acta ophthalmologica and the net. Acta Ophthalmol Scand (2003) 0.75
The Glaucoma Guidelines of the Swedish Ophthalmological Society. Acta Ophthalmol Suppl (Oxf ) (2012) 0.75
Comparison of clinicians and an artificial neural network regarding accuracy and certainty in performance of visual field assessment for the diagnosis of glaucoma. Acta Ophthalmol (2012) 0.75
Niels Ehlers 1930-2016. Acta Ophthalmol (2016) 0.75
Progress and lack of progress in glaucoma. Acta Ophthalmol (2010) 0.75